We have advised the founders and shareholders of LEP AG (LEP), the leading DACH provider of digital healthcare documentation solutions, on the sale of a majority stake to Storskogen.
LEP develops and maintains digital intervention catalogues and analytical tools for structured documentation in healthcare. The catalogues cover numerous occupational groups and support use cases ranging from workload analysis and treatment planning to billing support and regulatory reporting. LEP’s offering is deeply embedded in the healthcare systems of Switzerland, Germany, and Austria, and is expanding into long-term care and additional geographies.
The original shareholder group, including founders, previous employees, and Kantonsspital St. Gallen, is selling the company to facilitate its succession planning and position the company for its next phase. LEP’s existing management team, under the leadership of CEO Stefan Hieber, will remain on board and continue to lead the company’s strategic development. With this transaction, LEP is well-positioned to accelerate its growth and further expand its role in delivering innovative digital documentation solutions to healthcare providers across Europe.
Storskogen is an international group of businesses across trade, industry, and services. With a long-term ownership horizon, Storskogen acquires and develops leading small and medium-sized businesses across the Nordics, DACH region, the UK, and Singapore. The company is listed on Nasdaq Stockholm.
